Drew Sycoff Purchases 182,540 Shares of GlucoTrack, Inc. (NASDAQ:GCTK) Stock

GlucoTrack, Inc. (NASDAQ:GCTK) Director Drew Sycoff acquired 182,540 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were purchased at an average cost of $1.26 per share, with a total value of $230,000.40. Following the acquisition, the director now owns 2,951,258 shares of the company’s stock, valued at approximately $3,718,585.08. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

GlucoTrack Stock Performance

Shares of GlucoTrack stock opened at $0.46 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.22 and a quick ratio of 3.22. The firm has a market cap of $12.31 million, a P/E ratio of -1.24 and a beta of 0.29. The firm has a 50 day simple moving average of $0.38 and a 200 day simple moving average of $0.28. GlucoTrack, Inc. has a fifty-two week low of $0.13 and a fifty-two week high of $0.99.

GlucoTrack (NASDAQ:GCTK) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.10) earnings per share for the quarter.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.